Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry

Bente Glintborg, Inge Juul Sørensen, Anne Gitte Loft, Jakob Espesen, Hanne Lindegaard, Dorte Vendelbo Jensen, K. Danebod, Sabine Sparre Dieperink, Oliver Hendricks, Inger Marie Jensen Hansen, Asta Linauskas, Salome Kristensen, Lis Smedegaard Andersen, M. Hossein, H. Nordin, B. L. Andersen, Stavros Chrysidis, J.L. Raun, Natalia Manilo, Jolanta GrydehøjE. B. Dalgaard, Dorte Dalsgaard Pedersen, Niels Steen Krogh, Merete Lund Hetland

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Abstrakt


OriginalsprogEngelsk
ArtikelnummerFRI0190
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind76
Udgave nummerSuppl. 2
Sider (fra-til)553-554
Antal sider2
ISSN0003-4967
StatusUdgivet - 2017
Begivenhed Annual European Congress of Rheumatology, European League Against Rheumatism - Madrid, Spanien
Varighed: 14 jun. 201717 jun. 2017
http://www.congress.eular.org/

Konference

Konference Annual European Congress of Rheumatology, European League Against Rheumatism
Land/OmrådeSpanien
ByMadrid
Periode14/06/201717/06/2017
Internetadresse

Fingeraftryk

Dyk ned i forskningsemnerne om 'Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry'. Sammen danner de et unikt fingeraftryk.

Citationsformater